KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $51,565 | -57.4% | 28,807 | -7.3% | 0.00% | -100.0% |
| Q1 2023 | $120,940 | +75.5% | 31,090 | +53.4% | 0.00% | 0.0% |
| Q4 2022 | $68,908 | -35.0% | 20,267 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $106,000 | +27.7% | 19,423 | +5.1% | 0.00% | 0.0% |
| Q2 2022 | $83,000 | -38.5% | 18,474 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $135,000 | +14.4% | 18,379 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | +24.2% | 18,288 | +11.8% | 0.00% | 0.0% |
| Q3 2021 | $95,000 | -43.1% | 16,364 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $167,000 | +5.7% | 16,230 | +8.2% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | -31.6% | 14,998 | +0.5% | 0.00% | -50.0% |
| Q4 2020 | $231,000 | +2.7% | 14,916 | -3.4% | 0.00% | 0.0% |
| Q3 2020 | $225,000 | +14.8% | 15,444 | +49.1% | 0.00% | -33.3% |
| Q2 2020 | $196,000 | -13.7% | 10,356 | -12.2% | 0.00% | -25.0% |
| Q1 2020 | $227,000 | – | 11,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |